Cimlanod Completed Phase 2 Trials for Decompensated Heart Failure / Acute Heart Failure (AHF) / Heart Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02157506A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure